March: Colorectal Cancer Awareness Month

Colorectal cancer is the second deadliest cancer in Europe, with around 500,000 new diagnoses every year¹ and over 180,000 annual deaths³ in Europe alone.

The Importance of Prevention

Screening plays a key role in reducing both incidence and mortality, enabling early diagnosis and removal of precancerous lesions.
The FOB test (Fecal Occult Blood Test) is a practical, non-invasive, and effective screening method for detecting early-stage colorectal cancer or identifying precancerous polyps from a small fecal sample.

Eurospital’s Commitment

Eurospital stands alongside the scientific community in promoting early diagnosis by providing reliable solutions for the detection of fecal occult blood through turbidimetric technology, actively supporting laboratories in the prevention of colorectal cancer.